Last update :
03/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Aztreonam  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Azactam Australia, Austria, Belgium, Brazil, Chile, Colombia, Denmark, Ecuador, Finland, France, Germany, Great Britain, Greece, Ireland, Italy, Japan, Luxembourg, Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, United Arab Emirates, United States of America
Azaxil Brazil
Azthreonam Argentina, Brazil, Chile, Colombia, Peru, United States of America, Venezuela
Barex Spain
Cayston Belgium, Canada, Germany, Spain, Switzerland, United States of America
Monobac Mexico
Namy India
Primbactam Italy
Treonam Peru
Urobactam Spain
Vibactam Peru
Stability of mixtures   Injection   Stability of mixtures : Aztreonam     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Not specified 8,6 mg/ml
Injection   Aztreonam   
Injection   Ranitidine hydrochloride 0,5 mg/ml
23°C
4 Hour
Light 360
Level of evidence B
Glass NaCl 0,9% or Glucose 5% 20 mg/ml
Injection   Aztreonam   
Injection   Clindamycin phosphate 9 mg/ml
25°C
48 Hour
Light 432
Level of evidence D
Glass Sodium chloride 0,9% 8,6 mg/ml
Injection   Aztreonam   
Injection   Ranitidine hydrochloride 0,5 mg/ml
22°C-23°C
4 Hour
Light 360
Level of evidence B
Glass Sodium chloride 0,9% 200 mg/ml
Injection   Aztreonam   
Injection   Clindamycin phosphate 60 mg/ml
25°C
48 Hour
Light 644
Level of evidence B
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Clindamycin phosphate 3 & 6 mg/ml
22°C-23°C
48 Hour
Not specified 419
Level of evidence B+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Cefazolin sodium 5 & 20 mg/ml
23°C-25°C
48 Hour
Protect from light 426
Level of evidence A
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Gentamicin sulfate 0,2 & 0,8 mg/ml
25°C
8 Hour
Not specified 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Cefoxitin sodium 10 & 20 mg/ml
25°C
12 Hour
Not specified 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Tobramycin sulfate 0,2 & 0,8 mg/ml
25°C
48 Hour
Not specified 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 4 mg/ml
Injection   Aztreonam   
Injection   Vancomycin hydrochloride 1 mg/ml
32°C
7 Day
Not specified 284
Level of evidence B+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Clindamycin phosphate 3 & 6 mg/ml
4°C
7 Day
Protect from light 419
Level of evidence B+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Tobramycin sulfate 0,2 mg/ml
4°C
7 Day
Protect from light 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Tobramycin sulfate 0,2 & 0,8 mg/ml
4°C
7 Day
Protect from light 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Cefoxitin sodium 10 & 20 mg/ml
4°C
7 Day
Protect from light 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 4 mg/ml
Injection   Aztreonam   
Injection   Vancomycin hydrochloride 1 mg/ml
4°C
31 Day
Protect from light 284
Level of evidence B+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Gentamicin sulfate 0,2 & 0,8 mg/ml
4°C
24 Hour
Protect from light 19
Level of evidence D
Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 & 20 mg/ml
Injection   Aztreonam   
Injection   Cefazolin sodium 5 & 20 mg/ml
4°C-5°C
7 Day
Protect from light 426
Level of evidence A
Polyvinyl chloride Sodium chloride 0,9% 4 mg/ml
Injection   Aztreonam   
Injection   Vancomycin hydrochloride 1 mg/ml
23°C
31 Day
Not specified 284
Level of evidence B+
Polyvinyl chloride Sodium chloride 0,9% 10 mg/ml
Injection   Aztreonam   
Injection   Ampicillin sodium - sulbactam sodium 20 mg/ml
24°C
24 Hour
Not specified 258
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 10 mg/ml
Injection   Aztreonam   
Injection   Ampicillin sodium - sulbactam sodium 20 mg/ml
5°C
84 Hour
Not specified 258
Level of evidence D
Polyvinyl chloride Glucose 5% 4 mg/ml
Injection   Aztreonam   
Injection   Vancomycin hydrochloride 1 mg/ml
23°C
14 Day
Not specified 284
Level of evidence B+
Polyolefine None 20 mg/ml
Injection   Aztreonam   
Injection   Linezolid 2 mg/ml
23°C
7 Day
Protect from light 1658
Level of evidence B+
Polyolefine None 20 mg/ml
Injection   Aztreonam   
Injection   Linezolid 2 mg/ml
4°C
7 Day
Protect from light 1658
Level of evidence B+
Not specified Sodium chloride 0,9% 16,7 mg/ml
Injection   Aztreonam   
Injection   Daptomycin 16,7 mg/ml
22°C-28°C
2 Hour
Not specified 1937
Level of evidence C+
  Mentions Légales